Table 4.
Average Time Period in Months Between the Date Patients First Received Secukinumab (Therapy Start Date) and the Date Patients Were Enrolled in the Program (Program Start Date)
| Time Period, Months | No. of Patientsa | |
|---|---|---|
| April 2017–September 2017 | 5.7 | 69 |
| October 2017–March 2018 | 3.4 | 108 |
| April 2018–September 2018 | 4.2 | 79 |
| October 2018–March 2019 | 5.3 | 133 |
| April 2019–September 2019 | 3.4 | 75 |
| October 2019–March 2020 | 0.7 | 39 |
| April 2020–September 2020 | 0.6 | 9 |
Notes: aData was calculated on 512 patients as this data was not available for 13 patients.